Your browser doesn't support javascript.
loading
Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy.
Sanahuja, Jordi; Alonso, Núria; Diez, Javier; Ortega, Emilio; Rubinat, Esther; Traveset, Alícia; Alcubierre, Núria; Betriu, Àngels; Castelblanco, Esmeralda; Hernández, Marta; Purroy, Francisco; Arcidiacono, Maria Vittoria; Jurjo, Carmen; Fernández, Elvira; Puig-Domingo, Manuel; Groop, Per-Henrik; Mauricio, Dídac.
Afiliação
  • Sanahuja J; Department of Neurology, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Alonso N; Department of Endocrinology and Nutrition, Germans Trias i Pujol Health Science Research Institute and University Hospital, Badalona, Spain CIBERDEM, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Diez J; Institut de Diagnòstic per la Imatge, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Ortega E; Institut de Recerca Biomedica de Lleida, University of Lleida, Lleida, Spain.
  • Rubinat E; Department of Endocrinology & Nutrition, Institut d'Investigacions Biomediques August Pi Suñer, Centro de Investigación Biomédica en Red de la Obesidad y la Nutrición, Hospital Clinic, Barcelona, Spain.
  • Traveset A; Department of Ophthalmology, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Alcubierre N; Department of Endocrinology & Nutrition, Institut d'Investigacions Biomediques August Pi Suñer, Centro de Investigación Biomédica en Red de la Obesidad y la Nutrición, Hospital Clinic, Barcelona, Spain.
  • Betriu À; Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Castelblanco E; Department of Endocrinology and Nutrition, Germans Trias i Pujol Health Science Research Institute and University Hospital, Badalona, Spain.
  • Hernández M; Department of Endocrinology and Nutrition, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Purroy F; Department of Neurology, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Arcidiacono MV; Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Jurjo C; Department of Ophthalmology, University Hospital Arnau de Vilanova, Lleida, Spain.
  • Fernández E; Department of Endocrinology & Nutrition, Institut d'Investigacions Biomediques August Pi Suñer, Centro de Investigación Biomédica en Red de la Obesidad y la Nutrición, Hospital Clinic, Barcelona, Spain Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, University Hospital Arnau de V
  • Puig-Domingo M; Department of Endocrinology and Nutrition, Germans Trias i Pujol Health Science Research Institute and University Hospital, Badalona, Spain CIBERDEM, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Groop PH; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland; and Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
  • Mauricio D; Department of Endocrinology and Nutrition, Germans Trias i Pujol Health Science Research Institute and University Hospital, Badalona, Spain CIBERDEM, Instituto de Salud Carlos III (ISCIII), Madrid, Spain didacmauricio@gmail.com.
Diabetes Care ; 39(9): 1614-20, 2016 Sep.
Article em En | MEDLINE | ID: mdl-27281772
OBJECTIVE: We sought to examine the presence and severity of brain small vessel disease (SVD) in patients with type 2 diabetes and diabetic retinopathy (DR) compared with those without DR. RESEARCH DESIGN AND METHODS: We evaluated 312 patients with type 2 diabetes without previous cardiovascular disease (men 51%; mean age 57 years; age range 40-75 years); 153 patients (49%) had DR. MRI was performed to evaluate the presence and severity (age-related white matter changes scale) of white matter lesions (WMLs) and lacunes, and transcranial Doppler ultrasound was used to measure the Gosling pulsatility index (PI) of the middle cerebral artery (MCA). RESULTS: The prevalence of lesions of cerebral SVD (WML and/or lacunes) was higher in patients with DR (40.2% vs. 30.1% without DR, P = 0.04). Age (P < 0.01) and systolic blood pressure (P = 0.02) were associated with the presence of SVD. The severity of SVD was associated with age and the presence of DR (P < 0.01 and P = 0.01, respectively). Patients with DR showed a higher MCA PI compared with those without DR (P < 0.01). Age, systolic and diastolic blood pressure, and retinopathy and its severity were associated with an increased MCA PI (P < 0.01 for all variables). A positive correlation was found between MCA PI values and the presence and severity of SVD (P < 0.01 for both variables). CONCLUSIONS: Patients with type 2 diabetes who have DR have an increased burden of cerebral SVD compared with those without DR. Our findings suggest that the brain is a target organ for microangiopathy, similar to other classic target organs, like the retina.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Artéria Cerebral Média / Diabetes Mellitus Tipo 2 / Retinopatia Diabética / Doenças de Pequenos Vasos Cerebrais Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Artéria Cerebral Média / Diabetes Mellitus Tipo 2 / Retinopatia Diabética / Doenças de Pequenos Vasos Cerebrais Idioma: En Ano de publicação: 2016 Tipo de documento: Article